REAL-WORLD COSTS IN BIOLOGIC NAIVE PSORIATIC ARTHRITIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE

被引：0
|
作者：
Kaplan, D. [1 ]
Ung, B. [2 ]
Udeze, C. [3 ]
Pelletier, C. [3 ]
Tian, M. [3 ]
机构：
[1] Adult & Pediat Dermatol, Overland Pk, KS USA
[2] Celgene Corp, Morris Plains, NJ USA
[3] Celgene Corp, Summit, NJ USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS15
引用
收藏
页码：S888 / S888
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD COSTS IN BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE
    Kaplan, D.
    Ung, B.
    Pelletier, C.
    Udeze, C.
    Tian, M.
    VALUE IN HEALTH, 2019, 22 : S888 - S888
  • [2] Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics
    Feldman, Steven R.
    Pelletier, Corey L.
    Wilson, Kathleen L.
    Mehta, Rina K.
    Brouillette, Matthew A.
    Smith, David
    Bonafede, Machaon M.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (01) : 45 - 54
  • [3] COMPARISON OF PERSISTENCE AND ADHERENCE IN BIOLOGIC NAIVE PATIENTS WITH PSORIATIC ARTHRITIS INITIATING APREMILAST OR BIOLOGICS IN A US ADMINISTRATIVE CLAIMS DATABASE
    Feldman, S. R.
    Bonafede, M. M.
    Pelletier, C.
    Mehta, R.
    Brouillette, M.
    Smith, D.
    Wilson, K. L.
    Ni, Q.
    VALUE IN HEALTH, 2017, 20 (09) : A541 - A541
  • [4] Real-world switch patterns and healthcare costs in biologic-naive psoriasis patients initiating apremilast or biologics
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    Khilfeh, Ibrahim
    Curtis, Jeffrey R.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (11) : 767 - 779
  • [5] RATES OF REAL-WORLD TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE
    Kaplan, D.
    Ung, B.
    Pelletier, C.
    Udeze, C.
    Tian, M.
    VALUE IN HEALTH, 2019, 22 : S245 - S245
  • [6] Treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriatic arthritis: results from a US claims analysis
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (01) : 169 - 176
  • [7] Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (04) : 365 - 371
  • [8] Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis
    Feldman, Steven R.
    Pelletier, Corey L.
    Wilson, Kathleen L.
    Mehta, Rina K.
    Brouillette, Matthew A.
    Smith, David
    Bonafede, Machaon M.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (09) : 699 - 708
  • [9] SWITCH PATTERNS AND TOTAL HEALTHCARE COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIATIC ARTHRITIS: RESULTS FROM A US CLAIMS ANALYSIS
    Curtis, J. R.
    Pelletier, C.
    Ung, B.
    Tian, M.
    Ni, Q.
    Wu, J.
    VALUE IN HEALTH, 2018, 21 : S293 - S294
  • [10] REAL-WORLD SWITCH RATES AMONG BIOLOGIC-NAIVE PSORIATIC ARTHRITIS PATIENTS INITIATING APREMILAST, TUMOR NECROSIS FACTOR INHIBITORS OR INTERLEUKIN INHIBITORS
    Kaplan, David
    Ung, Brian
    Pelletier, Corey
    Udeze, Chuka
    Tian, Marc
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1287 - 1287
12345